FL

First Light Asset Management

North America, Illinois, United States, Hennepin

Description

First Light Asset Management invests in health care companies that offer high investment potential.

Investor Profile

First Light Asset Management has made 9 investments, with 4 in the past 12 months and 11% as lead.

Stage Focus

  • Post Ipo Equity (67%)
  • Private Equity (22%)
  • Convertible Note (11%)

Country Focus

  • United States (89%)
  • United Kingdom (11%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Biopharma
  • Medical
  • Therapeutics
  • Life Science
  • Genetics
  • Health Diagnostics
  • Machinery Manufacturing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does First Light Asset Management frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 2
Pura Vida Investments
North America, New York, United States, New York
Co-Investments: 3
Nantahala Capital Management
North America, Connecticut, United States, New Canaan
Co-Investments: 2
Farallon Capital Management
North America, California, United States, San Francisco
Co-Investments: 3
ClearBridge Investments
North America, New York, United States, New York
Co-Investments: 2
DC
North America, Illinois, United States, Chicago
Co-Investments: 3
Woodline Partners
North America, California, United States, San Francisco
Co-Investments: 3
Frazier Life Sciences
North America, California, United States, Menlo Park
Co-Investments: 2
Rock Springs Capital
North America, Maryland, United States, Baltimore
Co-Investments: 2
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 2

What are some of recent deals done by First Light Asset Management?

Eledon Pharmaceuticals

Irvine, California, United States

Eledon Pharmaceuticals is a biotechnology company developing treatments for people undergoing organ or cellular transplantation.

BiotechnologyHealth CareMedicalPharmaceutical
Post Ipo EquityOct 29, 2024
Amount Raised: $85,000,000
AnaptysBio

San Diego, California, United States

AnaptysBio is a biotechnology company that develops antibody therapeutics based on somatic hypermutation.

BiotechnologyHealth CareTherapeutics
Post Ipo EquityAug 14, 2024
Amount Raised: $100,000,000
Virocell Biologics

London, England, United Kingdom

Virocell Biologics is a contract development and manufacturing organization (CDMO) that manufactures viral vectors.

Machinery ManufacturingManufacturingMedical Device
Convertible NoteAug 14, 2024
Savara Pharmaceuticals

Austin, Texas, United States

Savara Pharmaceuticals develops an inhaled antibiotic for MRSA infection in cystic fibrosis.

BiopharmaBiotechnologyPharmaceutical
Post Ipo EquityJun 28, 2024
Amount Raised: $100,000,000
Crinetics Pharmaceuticals

San Diego, California, United States

Crinetics is a clinical-stage pharmaceutical company that develops therapies for people with rare endocrine diseases.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityFeb 28, 2024
Amount Raised: $350,000,000
Sonendo

Laguna Hills, California, United States

Sonendo is a healthcare company that focuses on developing innovative and disruptive technologies to transform endodontic therapy.

BiotechnologyHealth CareMedical
Post Ipo EquitySep 23, 2022
Amount Raised: $63,000,000
Caris Life Sciences

Irving, Texas, United States

Caris Life Sciences is a molecular science company that offers molecular profiling, tissue-based profiling, and testing services.

BiopharmaBiotechnologyHealth CareLife Science
Private EquityMay 11, 2021
Amount Raised: $830,000,000
NeoGenomics

Fort Myers, Florida, United States

NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists.

BiotechnologyGeneticsHealth CareHealth DiagnosticsMedicalPharmaceutical
Post Ipo EquityMay 5, 2021
Amount Raised: $200,000,000
Caris Life Sciences

Irving, Texas, United States

Caris Life Sciences is a molecular science company that offers molecular profiling, tissue-based profiling, and testing services.

BiopharmaBiotechnologyHealth CareLife Science
Private EquityOct 27, 2020
Amount Raised: $235,000,000